ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

60-Mile Limit For Primate Facility Dropped

June 9, 1978

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998